The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CHARTA: FOLFOX+bevacizumab +/- irinotecan in advanced colorectal cancer (CRC)—Final results of the randomized phase II trial of the AIO (KRK 0209).
 
Hans-Joachim Schmoll
Honoraria - Roche, GSK, Servier
Consulting or Advisory Role - Roche, Bayer, GSK
Research Funding - Roche, GSK
Travel, Accommodations, Expenses - Roche; Bayer, Servier; GSK
 
Benjamin Garlipp
No Relationships to Disclose
 
Christian Junghanss
No Relationships to Disclose
 
Malte Leithaeuser
No Relationships to Disclose
 
Arndt Vogel
No Relationships to Disclose
 
Michael Schaefers
No Relationships to Disclose
 
Ulrich Kaiser
No Relationships to Disclose
 
Heinz-Gert Hoeffkes
No Relationships to Disclose
 
Axel Florschütz
No Relationships to Disclose
 
Jörn Rüssel
No Relationships to Disclose
 
Stephan Kanzler
No Relationships to Disclose
 
Thomas Edelmann
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Thomas Goehler
No Relationships to Disclose
 
Carla Hannig
No Relationships to Disclose
 
Bert Hildebrandt
No Relationships to Disclose
 
Jörg Steighardt
No Relationships to Disclose
 
Fabian Maximilian Meinert
No Relationships to Disclose
 
Franziska Cygon
No Relationships to Disclose
 
Alexander Stein
Speakers' Bureau - Bayer; Celgene; Lilly; Roche; Sanofi
Research Funding - Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche